vanoxerine and caffeine

vanoxerine has been researched along with caffeine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Kuribara, H; Tadokoro, S; Uchihashi, Y1
Gasior, M; Goldberg, SR; Jaszyna, M; Shoaib, M; Yasar, S1
Jinnah, HA; Kasim, S1

Other Studies

4 other study(ies) available for vanoxerine and caffeine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Assessment of the ambulation-increasing effect of ketamine by coadministration with central-acting drugs in mice.
    Japanese journal of pharmacology, 1992, Volume: 60, Issue:1

    Topics: alpha-Methyltyrosine; Animals; Caffeine; Central Nervous System Agents; Central Nervous System Depressants; Ceruletide; Cocaine; Dizocilpine Maleate; Drug Synergism; Ketamine; Male; Methamphetamine; Methyltyrosines; Mice; Morphine; Motor Activity; Neurotransmitter Uptake Inhibitors; Nimodipine; Piperazines; Scopolamine

1992
Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:3

    Topics: Amphetamine; Analysis of Variance; Animals; Caffeine; Cocaine; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Piperazines; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Thiazepines

1999
Pharmacologic thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 73, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Caffeine; Calcium Channel Agonists; Central Nervous System Stimulants; Clonidine; Dystonia; Lesch-Nyhan Syndrome; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Movement Disorders; Pemoline; Piperazines; Self-Injurious Behavior

2002